SOFTMEDX-NEW：2022AnnualReport.pdf

1、ANNUAL REPORT2022CONTENTSPagesCorporate Information2Management Discussion and Analysis3Biographical Details of Directors5Report of the Directors6Corporate Governance Report10Environmental,Social and Governance Report14Independent Auditors Report17Consolidated Statement of Profit or Loss and other co

2、mprehensive income20Consolidated Statement of Financial Position21Consolidated Statement of Changes in Equity22Consolidated Statement of Cash Flows23Notes to the Consolidated Financial Statements24Five Years Financial Summary52SoftMedx Healthcare Limited2CORPORATE INFORMATIONBOARD OF DIRECTORSExecut

3、ive DirectorCHEUNG Wai KwanWANG JianguoIndependent Non-executive DirectorsHU XuezhenLIN Pinzhuo(appointed on 2 February 2023)YIU Chun Wing(appointed on 20 December 2022)AUDIT COMMITTEEYIU Chun Wing(Chairperson)HU XuezhenLIN PinzhuoNOMINATION COMMITTEELIN Pinzhuo(Chairperson)HU XuezhenYIU Chun WingRE

4、MUNERATION COMMITTEEHU Xuezhen(Chairperson)LIN PinzhuoYIU Chun WingRISK MANAGEMENT COMMITTEEYIU Chun Wing(Chairperson)LIN PinzhuoWANG JianguoCOMPANY SECRETARYLAM Sung Him,GastonSTOCK CODE648REGISTERED OFFICELevel 38,Infinitus Plaza199 Des Voeux Road CentralHong KongSHARE REGISTRARTricor Tengis Limit

5、ed17/F,Far East Finance Centre16 Harcourt RoadHong KongPRINCIPAL BANKERSBank of China(Hong Kong)LimitedThe Hong Kong and Shanghai Bank Corporation LimitedINDEPENDENT AUDITORSCL Partners CPA LimitedCertified Public AccountantsWEBSITE ADDRESS.hkAnnual Report 20223MANAGEMENT DISCUSSION AND ANALYSISREVI

6、EW OF FINANCIAL RESULTSSoftMedx Healthcare Limited(the“Company”,together with its subsidiaries,the“Group”)is principally engaged in medical and well-being business.For the year ended 31 December 2022,the Group recorded revenue of HK$33.8 million(2021:HK$1.7 million),gross profit of HK$13.7 million(2